Leading Global Telehealth and Medical Content Destination iCliniq Updates Contextual Capabilities With iCliniq Engage; an Enhanced Suite of Ad Solutions
Improved solution offers a valuable way for pharmaceutical companies to reach audiences in high-intent environment
Herdon, VA --News Direct-- iCliniq
iCliniq, a leading global provider of healthcare resources with operations in the U.S., U.K., UAE, India, Singapore and Germany, has rolled out an expanded version of iCliniq Engage; its suite of contextual advertising engagement solutions for pharmaceutical and medical advertisers. iCliniq Engage’s telehealth advertising solutions enable pharmaceutical companies a precise way to target display and video ads on more than 50,000 pieces of original, medically reviewed, high-intent, contextually relevant health content pieces to reach its highly-engaged audience.
“Each month, iCliniq attracts more than 700,000 unique patients, and they’re on a mission to find answers related to specific medical conditions,” said Dhruv Suyamprakasam, CEO of iCliniq. “By incorporating relevant medical advertisements alongside corresponding iCliniq content pages, we’re able to help pharma marketers get the precisely right messaging in front of appropriate patients, at the point of interest. We’re proud to be offering a targeted approach to pharmaceutical marketing.”
iCliniq Engage is providing pharmaceutical marketers with a Cost-Per-View (CPV) contextual advertising solution for reaching highly-engaged patients seeking specific information on various medical concerns and conditions. The updated ad solutions offering including:
Relevant Placements: Pharmaceutical advertisements can be placed within iCliniq's health article, telehealth Q&As, health tools, as well as asynchronous and synchronous consultation waiting rooms.
Keyword Association: iCliniq compiles a list of relevant keywords associated with any pharmaceutical and the corresponding links on the iCliniq website that align with the patient journey.
Patient Stories: iCliniq consistently features patient success stories of those who have benefited from pharmaceutical treatment. The patient journey links showcase how the ads will be displayed on iCliniq's content pages.
Building Awareness and Engagement: iCliniq contributes to building awareness and driving engagement with pharmaceuticals among appropriate target audiences. iCliniq has the ability to add the benefits of a treatment and can provide video and infographic content.
This iCliniq Engage update builds on the company’s existing offerings in the U.S., which includes the recently-launched, real-time asynchronous consultations with primary care physicians as well as second opinion telehealth visits. Additionally, iCliniq’s telemedicine services offer video and text-based consultations with U.S. physicians, as well as access to prescriptions and builds on the company’s existing second opinion consultation and deep library of original medical content which has already attracted an audience of 15 million U.S. consumers.
“It’s incredibly valuable for pharma marketers to leverage contextual targeting with a high intent, highly engaged consumer seeking medical advice, and iCliniq delivers this at scale,” said Samantha Brown, VP of Media at Evoke. “As a direct-to-consumer media and marketing professional, it’s impressive to see the way iCliniq’s audience interacts with the platform’s doctor-authored content, demonstrating engagement and intent. We’re excited to learn more about iCliniq Engage as a tool for pharma marketers.”
iCliniq is certified as a HIPAA-compliant platform, offering the highest level of data protection while also adhering to internationally recognized NIST-security standards. iCliniq is also compliant with GDPR regulations which safeguard personal information from unauthorized access and regulate its transfer over the Internet.
iCliniq, founded in 2012, is the leading global provider of virtual healthcare resources. Its virtual online medical service provides convenient, premier health care to more than 190 countries. iCliniq’s doctor panel consists of more than 3,500 highly qualified doctors from 80+ specialties in the U.S., U.K., UAE, India, Singapore and Germany. The company is headquartered in Coimbatore, Tamil Nadu, India and has offices in the United States. iCliniq has been rated among the top telemedicine portals in the world by CPoE, Parade, and Insider. For more information, visit https://www.icliniq.com/.
Contact Details
Maggie Stasko
+1 724-787-1565
Company Website
View source version on newsdirect.com: https://newsdirect.com/news/leading-global-telehealth-and-medical-content-destination-icliniq-updates-contextual-capabilities-with-icliniq-engage-an-enhanced-suite-of-ad-solutions-340526701
